FDNA Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 38

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $27.5M

  • Investors
  • 2

FDNA General Information

Description

Developer of an artificial intelligence-based phenotyping technology designed to analyze relevant genomic and phenotypic information. The company's technology detects physiological patterns that reveal disease-causing genetic variations, which are analyzed and included in their comprehensive database of clinically relevant genomic and phenotypic information, enabling clinicians, labs, and researchers to address genetic disease problems in healthcare.

Contact Information

Website
www.fdna.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 309 East Paces Ferry Road
  • Suite 400
  • Atlanta, GA 30305
  • United States
+1 (954)
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 309 East Paces Ferry Road
  • Suite 400
  • Atlanta, GA 30305
  • United States
+1 (954)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FDNA Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC (Series B) $27.5M Completed Generating Revenue
To view FDNA’s complete valuation and funding history, request access »

FDNA Patents

FDNA Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3635595-A1 Systems, methods, and computer-readable media for gene and genetic variant prioritization Pending 08-Jun-2017
US-10470659-B2 Systems, methods, and computer-readable media for gene and genetic variant prioritization Active 08-Jun-2017
US-20180353072-A1 Systems, methods, and computer-readable media for gene and genetic variant prioritization Active 08-Jun-2017
WO-2018227154-A1 Systems, methods, and computer-readable media for gene and genetic variant prioritization Inactive 08-Jun-2017
US-10327637-B2 Systems, methods, and computer-readable media for patient image analysis to identify new diseases Active 08-Jun-2017 A61B5/0013
To view FDNA’s complete patent history, request access »

FDNA Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FDNA Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Clal Biotechnology Industries Venture Capital Minority
Nacre Capital Venture Capital Minority
To view FDNA’s complete investors history, request access »

FDNA FAQs

  • When was FDNA founded?

    FDNA was founded in 2011.

  • Where is FDNA headquartered?

    FDNA is headquartered in Atlanta, GA.

  • What is the size of FDNA?

    FDNA has 38 total employees.

  • What industry is FDNA in?

    FDNA’s primary industry is Decision/Risk Analysis.

  • Is FDNA a private or public company?

    FDNA is a Private company.

  • What is the current valuation of FDNA?

    The current valuation of FDNA is .

  • What is FDNA’s current revenue?

    The current revenue for FDNA is .

  • How much funding has FDNA raised over time?

    FDNA has raised $27.5M.

  • Who are FDNA’s investors?

    Clal Biotechnology Industries and Nacre Capital have invested in FDNA.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process